MiR-194-5p was found deregulated in AML patients, and its restoration induces cell differentiation and apoptosis by targeting BCL2 associated transcription factor 1 (BCLAF1) [154]. The gene discussed is BCLAF1; the disease is acute myeloid leukemia.